Ragweed allergy vaccine sublingual - Lofarma SpA
Alternative Names: Lais AmbrosiaLatest Information Update: 27 Dec 2019
At a glance
- Originator Lofarma S.p.A
- Class Allergens; Antiallergics; Plant allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Seasonal allergic rhinitis
Most Recent Events
- 27 Dec 2019 No development reported - Phase-II for Seasonal allergic rhinitis in Italy (Sublingual) (Lofarma SpA website, December 2019)
- 06 May 2012 Phase-II clinical trials in Seasonal allergic rhinitis in Italy (Sublingual)